PhRMA chief plays fa­vorites in sin­gling out Mar­tin Shkre­li as a ‘bad ac­tor’; Roche ex­tends an­tibi­otics col­lab­o­ra­tion

→ PhRMA CEO Steve Ubl en­joys hold­ing up Tur­ing’s Mar­tin Shkre­li as an ex­am­ple of the kind of “bad ac­tors” that are giv­ing phar­ma com­pa­nies a bad name. The Boston Busi­ness Jour­nal not­ed that Ubl sin­gled out Shkre­li in a Q&A with re­porters. But what about Marathon CEO and PhRMA board mem­ber Jeff Aronin, who finds him­self at the cen­ter of a tem­pest over the ap­proval of de­flaza­cort?  STAT notes: “Ubl wouldn’t say what kind of com­pa­nies might get the boot from PhRMA once the mem­ber­ship cri­te­ria are re­vised. But he said the re­vi­sion process ‘should take weeks not months.’ He al­so con­firmed that while Marathon is still a PhRMA mem­ber, it’s pos­si­ble that af­ter the re­view it might not be.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.